 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy Lineage Cell Therapeutics stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:LCTX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Lineage Cell Therapeutics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also develops Renevia, a facial aesthetics product that is in clinical trial for the treatment of HIV-associated facial lipoatrophy; HyStem, a biomaterial used for cell replacement and retention; and Premvia, a Hystem Hydrogel product, as well as develops bone grafting products for the orthopedic diseases and injuries. In addition, the company offers various therapeutic products for the treatment of oncology, neurological diseases and disorders, blood and vascular system diseases and disorders, and blood plasma volume expansion, as well as undertakes various research programs for vision restoration and Demyelination. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Volume médio
2.16 million shs
MERCADO CAP
$416.97 million
Bolsa de Valores
NYSEAMERICAN
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
AMEX: LCTX
|
Produtos biológicos, exceto produtos de diagnóstico
|
Médico
|
39,559 shs
|
Below is a quick guide on how to buy AMEX:LCTX stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy Lineage Cell Therapeutics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy Lineage Cell Therapeutics – Search for “”AMEX:LCTX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Lineage Cell Therapeutics stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
5 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Lineage Cell Therapeutics in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Lineage Cell Therapeutics stock.
Wall Street analysts have given Lineage Cell Therapeutics a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Lineage Cell Therapeutics wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:LCTX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Lineage Cell Therapeutics stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Lineage Cell Therapeutics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “AMEX:LCTX stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some AMEX:LCTX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:LCTX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Lineage Cell Therapeutics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Lineage Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for Lineage Cell Therapeutics.
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) released its quarterly earnings results on Wednesday, November, 4th. The company reported ($0.05) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.05). The company earned $0.57 million during the quarter, compared to the consensus estimate of $0.65 million. Lineage Cell Therapeutics had a negative net margin of 1,001.59% and a negative trailing twelve-month return on equity of 26.07%.
View Lineage Cell Therapeutics’ earnings history.
5 brokers have issued 1 year price objectives for Lineage Cell Therapeutics’ shares. Their forecasts range from $3.00 to $6.00. On average, they anticipate Lineage Cell Therapeutics’ stock price to reach $4.33 in the next year. This suggests a possible upside of 55.9% from the stock’s current price.
View analysts’ price targets for Lineage Cell Therapeutics or view top-rated stocks among Wall Street analysts.
Lineage Cell Therapeutics’ management team includes the following people:
Mr. Brian M. Culley, CEO, Pres & Director (Age 50, Pay $772.74k)
Ms. Brandi L. Roberts, Chief Financial Officer (Age 47, Pay $550.01k)
Mr. Chase C. Leavitt, Gen. Counsel & Corp. Sec. (Age 40, Pay $321.79k)
Ioana C. Hone, Diretora de Relações com Investidores
Mr. James Knight, Sr. VP & Head of Corp. Devel.
Dr. François Binette M.Sc., Ph.D., Sr. VP & Global Head of R&D
Dr. Gary S. Hogge D.V.M., Dvm, Ms, Ph.D., Sr. VP of Clinical & Medical Affairs (Age 53)
Mr. William Annett, Pres & CEO of OncoCyte Corp. (Age 67)
Dr. Rami Skaliter, Chief Exec. Officer of Cell Cure Neurosciences Ltd. (Age 63)
Dr. Harold D. Waitz, VP of Regulatory Affairs & Quality Control (Age 79)
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:LCTX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
Some companies that are related to Lineage Cell Therapeutics include Inhibrx (INBX), Adverum Biotechnologies (ADVM), Krystal Biotech (KRYS), Cortexyme (CRTX), Coherus BioSciences (CHRS), Vaxcyte (PCVX), Taysha Gene Therapies (TSHA), Mesoblast (MESO), Cellectis (CLLS), Rubius Therapeutics (RUBY), Black Diamond Therapeutics (BDTX), Sutro Biopharma (STRO), Passage Bio (PASG), Agenus (AGEN) and TCR2 Therapeutics (TCRR).
View all of LCTX’s competitors.
Based on aggregate information from Reportlab, some companies that other Lineage Cell Therapeutics investors own include Matinas BioPharma (MTNB), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), ADMA Biologics (ADMA), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI), Cannabics Pharmaceuticals (CNBX), Enerplus (ERF), KushCo (KSHB) and Zosano Pharma (ZSAN).
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
Lineage Cell Therapeutics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “LCTX.”
Lineage Cell Therapeutics’ stock is owned by a number of institutional and retail investors. Top institutional shareholders include Defender Capital LLC. (3.16%), BlackRock Inc. (1.07%) and Wealth Architects LLC (0.01%). Company insiders that own Lineage Cell Therapeutics stock include Brian M Culley, Broadwood Partners, LP and Chase C Leavitt.
View institutional ownership trends for Lineage Cell Therapeutics.
LCTX stock was sold by a variety of institutional investors in the last quarter, including Defender Capital LLC..
View insider buying and selling activity for Lineage Cell Therapeutics or view top insider-selling stocks.
LCTX stock was bought by a variety of institutional investors in the last quarter, including Wealth Architects LLC, and BlackRock Inc.. Company insiders that have bought Lineage Cell Therapeutics stock in the last two years include Brian M Culley, Broadwood Partners, LP, and Chase C Leavitt.
View insider buying and selling activity for Lineage Cell Therapeutics or or view top insider-buying stocks.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
Shares of LCTX can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of LCTX stock can currently be purchased for approximately $2.78.
Lineage Cell Therapeutics has a market capitalization of $416.97 million and generates $3.52 million in revenue each year. The company earns $-11,710,000.00 in net income (profit) each year or $0.14 on an earnings per share basis.
Lineage Cell Therapeutics employs 50 workers across the globe.
The official website for Lineage Cell Therapeutics is www.lineagecell.com.
Lineage Cell Therapeutics is headquartered at 2173 SALK AVENUE SUITE 200, CARLSBAD CA, 92008.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How can you buy Lineage Cell Therapeutics stock on the internet?
You can easily buy Lineage Cell Therapeutics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Outra opção é usar um corretor regulamentado como Mercados de IC ou Corretores Interativos. You can an account with these brokers and start buying or trading AMEX:LCTX stocks in a safe and complete environment to trade in.
Where to buy Lineage Cell Therapeutics stock?
You will first want to find a licensed broker that supports AMEX:LCTX stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:LCTX stocks in a safe and complete environment.
Is AMEX:LCTX stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:LCTX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Lineage Cell Therapeutics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:LCTX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Lineage Cell Therapeutics stock.
How do you trade Lineage Cell Therapeutics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Lineage Cell Therapeutics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:LCTX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Lineage Cell Therapeutics stock?
To sell your AMEX:LCTX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Lineage Cell Therapeutics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:LCTX stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
